Series date: 
07/01/2021 - 7:00am CDT to 06/30/2022 - 4:00pm CDT

Please check the individual session for location or broadcast availability.  



Series Director

Frank Y. Lin, MD

Target Audience and Needs

Pediatric oncologists, geneticists, molecular and anatomic pathologists, surgeons, genetic counselors, medical trainees, and other healthcare professionals involved in the care of pediatric patients with cancer need to be regularly updated with the recent advances and guidelines in the field of pediatric oncology. The tumor board aims to increase knowledge of the learners using a multidisciplinary case approach, and encourages learners to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Educational Methods

Educational methods will include case presentations and panel discussion.


At the conclusion of the sessions, the participants should be able to:

  • Apply the results of tumor and germline molecular testing to the diagnosis, prognosis, and treatment of pediatric cancer.
  • Demonstrate the expanding role of molecular diagnostics in formulating pediatric precision-oncology treatment strategies.
  • Use a multidisciplinary approach in interpreting results of molecular diagnostics.
  • Appraise the molecular tests currently available in pediatric oncology and recognize the limitations and risks of using them.


Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator 

MacKenzie Harris

Series location: 
Texas Children's Hospital
6621 Fannin Street
Houston, TX 77030
United States


Session Date
QA Presentations: A Teen with Polymorphous Low-Grade Neuroepithelial Tumor Harboring an FGFR2/INA Fusion / A Preteen with Recurrent High-Grade Glioma Harboring H3F3A, G34V, and ATRX Mutations and a PTEN Variant 09/08/2021 - 12:00pm to 1:00pm CDT
QA Presentations: A Teenaged Boy with Low-Grade Glioma Harboring an EWSR1-PATZ1 Fusion/A School-Aged Boy with Medulloblastoma and a Germline TP53 Pathogenic Variant 10/13/2021 - 12:00pm to 1:00pm CDT
QA Presentations: A Preschool-Aged Girl with a H3K27-Altered Diffuse Midline Glioma Harboring a HIST1H3B Mutation / An Adolescent Girl with Xp11 Translocation Renal Cell Carcinoma Harboring a PRCC/TFE3 Fusion 11/10/2021 - 12:00pm to 1:00pm CST
QA Presentations: A Preadolescent Boy with Pilocytic Astrocytoma Harboring an NTRK2 Fusion/A Toddler Girl with an Embryonal Tumor That Has Multi-layered Rosettes and C19mc Amplification 01/12/2022 - 12:00pm to 1:00pm CST
QA Presentations: Tumor and Germline Genetics of Pediatric Ovarian Tumors/An Adolescent with an Ovarian Germ Cell Tumor and Noonan Syndrome/An Adolescent with an Ovarian Borderline Mucinous Tumor Harboring KRAS and GNAS Mutations 02/09/2022 - 12:00pm to 1:00pm CST
QA Presentations: An Adolescent Female with a History of Acute Lymphocytic Leukemia, Bilateral Renal Cell Carcinoma, and Bilateral Optic Pathway Glioma/A Newborn Girl with a Small-Bowel Spindle Cell Neoplasm that Has Rare BRAF Variants 03/09/2022 - 12:00pm to 1:00pm CST
QA Presentations: An Infant with a Small-Bowel Spindle Cell Neoplasm that Contains Mutations in BRAF and An Infant with High-grade Glioma Harboring an ROS1 Fusion 04/13/2022 - 12:00pm to 1:00pm CDT